Huawei провела глобальную презентацию новых флагманских продуктов в Мюнхене

Huawei провела глобальный запуск новых продуктов в Мюнхене, усилив линейку носимых устройств и здоровья: WATCH GT 7 (включая WATCH GT 7 Pro) получил на запястье определение и G-Force, а также ИИ-аналитику тренировок и функцию Physical Readiness; новый WATCH D3 — запястной тонометр с измерением АД до/после упражнений (CE-MDR). В сегменте умных часов Huawei, по данным Counterpoint Research, заняла 22% мировых отгрузок во 2К 2026 (+2 п.п. к Apple при -4% рынка). Компания также представила MatePad Pro с 12" гибким OLED (454 г) и серию смартфонов nova 16s с камерой 200 МП и функциями интеллектуального редактирования, что поддерживает позитивный тон вокруг расширения продуктовой линейки и ИИ-функций.

Analysis

This looks more like a share-defense event than a clean earnings catalyst. The market mechanism is ecosystem stickiness: if Huawei can keep users inside its health, watch, and phone stack, it reduces churn and raises lifetime value even if handset hardware margins stay thin. That matters most for Apple, where wearables are less about near-term revenue and more about maintaining premium ecosystem control in China and parts of Europe.

The bigger second-order issue is category price pressure. A credible push into medical-grade health features and sports telemetry can pull mid-tier devices toward commoditized specs, which is negative for brands relying on software differentiation rather than distribution. Garmin is the cleaner operating-risk name than Apple if Huawei’s sports/health features start showing up in European retail sell-through, but the evidence is still mostly branding and not yet P&L.

Near term, this should not move fundamentals in days; it becomes actionable only if the next 1-2 quarters show sustained share gain or weaker channel inventory at Apple/competitors. Over 6-18 months, the key falsifier is whether Huawei can monetize the feature lead outside China without discounting—if not, the launch is mostly optics and the competitive impact fades. Conversely, if Apple’s China hardware commentary softens or Garmin’s premium growth stalls, this becomes a real multiple-risk story rather than just a product-news headline.

Key Decisions for Investors

• Do not chase the announcement day; wait for channel checks and the next AAPL earnings print. If Greater China revenue or Wearables growth re-accelerates, stay flat; if it disappoints again, consider a 6-month AAPL put spread as a capped-risk hedge into the next product cycle.
• Watch GRMN for the first evidence that Huawei’s health/sports features are taking share in Europe. A small short only makes sense after a guide-down or a clear break in premium unit growth; otherwise the brand moat is still too strong for a clean trade.
• If follow-up data shows Huawei’s launch translating into sustained domestic hardware demand, consider a relative-value basket long 1810.HK / 2382.HK versus short AAPL, but only after 1-2 quarters of confirmation. The trade is about China OEM momentum, not a one-day launch reaction.
• Set a thesis stop: if AAPL services and hardware commentary stabilizes or Garmin maintains double-digit watch growth, abandon the share-loss narrative. The upside from this news is likely capped unless it turns into repeatable sell-through data.